Functional Electrical Stimulation Market Expected to Reach USD 931.4 Million by 2033, Growing at 4.1% CAGR

Functional Electrical Stimulation Market
Functional Electrical Stimulation Market

The global functional electrical stimulation (FES) market is projected to be valued at USD 620.9 million in 2023 and is anticipated to grow to approximately USD 931.4 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.1% over the forecast period.

The market’s expansion is primarily driven by the increasing incidence of spinal cord injuries, which are contributing to a higher demand for effective rehabilitation and therapeutic solutions. From 2018 to 2022, the FES market registered a CAGR of 2.6%, highlighting a steady growth trajectory.

Advancements in functional electrical stimulation technologies are enhancing treatment options and improving patient outcomes, further fueling market growth. As the healthcare sector continues to innovate and address the needs of individuals with spinal cord injuries, the FES market is poised for significant development, offering promising opportunities for stakeholders in the coming years.

Future Market Insights, in its latest business report, elaborates on the current situation of the global Functional Electrical Stimulation market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects.

Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMI’s latest report on the Functional Electrical Stimulation market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

A Old Full Report Analysis Click Here

Functional Electrical Stimulation Market: Segmentation

By Product Type:

  • Wired Devices
  • Wireless Devices

By Indication:

  • Neurological Disorders
  • Pain Management
  • Musculoskeletal Disorders
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Dysmenorrhea Treatment Market Expected to Reach USD 13,906.5 Million by 2033, Growing at 8.3% CAGR

Dysmenorrhea Treatment Market
Dysmenorrhea Treatment Market

The global dysmenorrhea treatment market, valued at USD 5,937.8 million at the end of 2022, is anticipated to grow to USD 6,324.5 million in 2023. The market is projected to expand at a robust compound annual growth rate (CAGR) of 8.3% from 2023 to 2033, reaching an estimated USD 13,906.5 million by the end of the forecast period.

Dysmenorrhea, commonly known as menstrual cramps, involves severe abdominal pain that may extend to the lower legs and back, typically beginning during adolescence, a few years after the onset of menstruation. This condition affects a significant number of women, driving the demand for effective treatment options.

The market’s growth is fueled by the increasing prevalence of dysmenorrhea and ongoing advancements in treatment modalities, providing more effective solutions for managing this painful condition. As the healthcare industry continues to innovate and improve treatment options, the dysmenorrhea treatment market is set to experience substantial growth, offering new opportunities for addressing the needs of women worldwide.

Dysmenorrhea, a prevalent condition affecting women globally, is characterized by painful menstruation. Prostaglandins, hormones generated in the uterine lining during menstruation, play a pivotal role in triggering uterine muscle spasms that cause pain and limit uterine blood flow and oxygen. Various underlying diseases can contribute to menstrual issues, emphasizing the need for effective dysmenorrhea treatment solutions.

The team of analysts at Future Business Insights are focussing on research and market study to produce different Dysmenorrhea Treatment Market forecasts and predictions at both national and international levels. They have considered several leads of information on the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Dysmenorrhea Treatment Market.

Global Dysmenorrhea Treatment Industry Key Companies Profiled:

  • Novartis Pharmaceuticals Corporation,
  • Merck, Inc.,
  • Bayer Schering Pharma AG,
  • Vanita Therapeutics,
  • Alvogen,
  • Pfizer, Inc.,
  • Nua
  • Cora
  • Roche Laboratories,
  • Taj Pharmaceuticals, Ltd.,
  • Sanofi,
  • Terramedic, Inc.

A Old Full Report Analysis Click Here

Key Segments Profiled In The Global Dysmenorrhea Treatment Industry

Global Dysmenorrhea Treatment Industry By Diseases:

  • Primary Dysmenorrhea
  • Secondary Dysmenorrhea
  • Endometriosis
  • Adenomyosis
  • Uterine Myomas
  • Endometrial Polyps
  • Cervical Stenosis
  • Obstructive Malformations Of Genital Tract

Global Dysmenorrhea Treatment Industry By Therapeutic Class:

  • Non-Hormonal Medical Treatment
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Non-Selective Nsaids
  • Cox-2 Inhibitors
  • Transdermal Glyceryl Trinitrate
  • Over-The-Counter (Otc) Medications
  • Hormonal Medicine Treatment
  • Combined Oral Contraceptive
  • Progestin Regimens
  • Levonorgestrel Intrauterine System (LN-IUS)
  • Surgical Options
  • Laparoscopy
  • Hysterectomy
  • Presacral Neurectomy
  • Laparoscopic Uterosacral Nerve Ablation (LUNA)
  • Intrauterine Device (IUD)

Global Dysmenorrhea Treatment Industry By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APAC
  • Japan
  • MEA

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Cloud-Based Drug Discovery Platform Market to Surge to USD 7,529.59 Million by 2032, Fueled by 12.6% CAGR

Cloud-Based Drug Discovery Platform Market
Cloud-Based Drug Discovery Platform Market

The global cloud-based drug discovery platform market is set for substantial expansion, with an anticipated valuation of USD 7,529.59 million by 2032, up from USD 2,424.33 million in 2022. This growth represents a robust compound annual growth rate (CAGR) of 12.6% over the forecast period.

Key factors driving this market surge include escalating investments in drug discovery, development, and manufacturing by pharmaceutical and biopharmaceutical companies, coupled with the rising adoption of cloud services for these activities. Cloud technology enhances operational efficiency, facilitates the development of business cases for assessing the viability of new medicines, and streamlines discovery and development processes.

The use of cloud services significantly reduces the high costs associated with research and development by accelerating drug discovery and minimizing the risk of errors. Additionally, the increasing prevalence of various diseases and the subsequent rise in investment for drug discovery are expected to further propel market growth.

As cloud technology continues to evolve and its applications in drug discovery expand, the market is poised to experience accelerated growth, offering new opportunities for innovation and efficiency in the pharmaceutical industry.

The benefits of cloud-based drug discovery platforms are enormous, and this is one of the key factors why it is gaining traction among end-users. This platform helps customers overcome many challenges by leveraging a network of web and mobile-accessible applications. It provides secure and collaborative project management and the ability to share project information. Moreover, the cloud-based drug discovery platform is flexible to offer end-users to customize it according to their projects.

Currently, cloud-based drug discovery platforms is witnessing a period of technological advancement, as innovative features, such as publishing and sharing services are being offered to users. Cloud-based drug discovery platform is accessible through computers, notebooks, and mobiles, and it is secure and can be maintained by a third party as well. Owing to all these factors, the cloud-based drug discovery platform market is anticipated to grow at a significant rate in terms of value.

Cloud-Based Drug Discovery Platform Market Dynamics

Data management is a critical issue for the pharmaceutical industry.  The pharmaceutical industry is rapidly restructuring its discovery business model to completely networked and integrated research and development to manage the huge data it generates. Storing this data on the cloud not only offers cost savings but also improved accessibility.

Graphical representation, a dynamic and quick form of getting results, helps in decision-making at a management level. Keeping the needs of consumers in mind, key players in the cloud-based drug discovery platform are offering flexible, cost-effective, and highly secure cloud-based storage options to consumers. Cloud-based drug discovery platform runs at zero lag time, saving time and giving real-time access to users. This is another reason for the growing adoption of cloud-based drug discovery platforms globally.

Confidentiality and privacy issues continue to impede the growth of the cloud-based drug discovery platform market. Although many improvements have been made in the recent past, cyber hacks continue to create apprehension among many pharma players, leading to stifled adoption.

North America, Japan, and Western Europe regions are some of the key players in the Global Cloud Based Drug Discovery Platform Industry. Many pharma companies based in these regions have already adopted cloud-based drug discovery platform, and it is anticipated that in the future, more companies will follow suit. The growth of the market in Asia Pacific excluding Japan (APEJ) is expected to gain momentum during the forecast period 2016-2026.

Cloud-Based Drug Discovery Platform Market Key Players:

Some of the key players operating in the Global Cloud Based Drug Discovery Platform Industry IBM Corp, Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec (Shanghai) Co., Ltd., Dassault Systemes BIOVIA Ltd.

The report covers an exhaustive analysis on:

  • Global Cloud-Based Drug Discovery Platform Market Segments
  • Global Cloud-Based Drug Discovery Platform Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Global Cloud-Based Drug Discovery Platform Market Size & Forecast 2016 to 2026
  • Supply & Demand Value Chain
  • Global Cloud-Based Drug Discovery Platform Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Global Cloud Based Drug Discovery Platform Industry Drivers and Restraints

Regional analysis for the Cloud-Based Drug Discovery Platform Market includes

  • North America
    • US & Canada
  • Latin America
    • Brazil, Mexico, Others
  • Western Europe
    • EU5
    • Nordics
    • Benelux
  • Eastern Europe
  • Asia Pacific
    • Australia and New Zealand (ANZ)
    • Greater China
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Japan
  • Middle East and Africa
    • GCC Countries
    • Other Middle East
    • North Africa
    • South Africa
    • Other Africa

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

A Old Full Report Analysis Click Here

Cloud-Based Drug Discovery Platform Market Segmentation

Based on the types of services

  • infrastructure as a Service (IaaS)
  • Platform as a Service (PaaS)
  • Software as a Service (SaaS)

Geographically, the global cloud-based drug discovery market is segmented into 

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East and Africa (MEA)

Report Highlights:

  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Digital Stethoscope Market Projected to Reach USD 539.6 Million by 2034, Growing at 5.7% CAGR

Digital Stethoscope Market
Digital Stethoscope Market

The global digital stethoscope market is set to grow from an estimated USD 310.0 million in 2024 to approximately USD 539.6 million by 2034. This expansion reflects a compound annual growth rate (CAGR) of 5.7% over the next decade.

The steady growth of the digital stethoscope market is driven by ongoing advancements in digital health technology and the increasing adoption of sophisticated diagnostic tools in medical practice. As healthcare professionals seek more accurate and efficient means of monitoring patient health, digital stethoscopes are becoming integral to modern clinical settings.

This upward trajectory highlights the growing importance of digital stethoscopes in enhancing diagnostic capabilities and improving patient outcomes through advanced technology.

Digital stethoscopes are revolutionizing patient care by offering enhanced sound quality, electronic data recording, and seamless integration with modern healthcare technologies. This advancement is not only improving diagnostic accuracy but also facilitating telemedicine and remote patient monitoring.

Key Takeaways:

  • The digital stethoscope market is estimated at US$310.0 million in 2024 and is projected to reach US$539.6 million by 2034, growing at a CAGR of 5.7%.
  • Rising adoption by healthcare professionals seeking smarter examination methods is a key driver.
  • Increasing prevalence of respiratory and cardiovascular diseases is fueling demand for advanced diagnostic tools.
  • Growing geriatric population creates a larger patient base for examinations using digital stethoscopes.
  • Enhanced functionalities like sound amplification, recording, and improved detection capabilities make digital stethoscopes a compelling choice.

Competitive Landscape in the Digital Stethoscope Market:

A small number of trustworthy businesses control a sizable portion of the industry. There is still space in the market, nevertheless, for small and medium-sized businesses to grow. There’s a lot of startup culture in the market, and these companies want to stand out from the competition by offering unique items.

Like other businesses in the healthcare space, companies involved in the digital stethoscope market aim to work together with other medical companies in order to broaden their market reach. For a significant number of market participants, acquisitions and mergers are also components of their strategy.

Recent Developments in the Digital Stethoscope Market

  • In a study published in November 2023, it was posited that AI-enabled digital stethoscopes could be used to detect peripartum cardiomyopathy in pregnant women.
  • In September 2023, FIGS, Inc. and Eko Health Inc. joined forces to launch the FIGS | Eko CORE 500 Digital Stethoscope. The stethoscope boasts of having unrivaled noise filtration and clarity of sounds picked from hearts and lungs.
  • In October 2022, Ai Health Highway India launched the AiSteth digital stethoscope. The digital stethoscope was developed with the aim of making the work of medical professionals in rural areas easier.
  • In April 2022, the Centre for Development of Advanced Computing (C-DAC) in India launched a wireless electronic stethoscope. The stethoscope allows doctors to remotely examine patients.

Key Companies in the Digital Stethoscope Market:

  • FarmaSino Pharmaceuticals
  • Contec Medical Systems
  • Hefny Pharma Group
  • Eko Health Inc.
  • 3M
  • Think Labs Medical LLC
  • TeleSensi
  • American Diagnostics
  • EKuore
  • Hill-Rom

A Old Full Report Analysis Click Here

Key Segments:

By Product Type:

  • Amplifying Stethoscope
  • Digitalization Stethoscope

By Technology:

  • Integrated Chest-Piece System
  • Wireless Transmission System (Bluetooth)
  • Integrated Receiver Head-Piece System
  • Numerical Simulation and System Integration

By End User:

  • Hospitals
  • Clinics
  • Healthcare Institutes & Organizations
  • Home Care Settings
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Cell Therapy Manufacturing Market to Surge to USD 15,634.67 Million by 2033, Growing at 14.2% CAGR

Cell Therapy Manufacturing Market
Cell Therapy Manufacturing Market

The global cell therapy manufacturing market is projected to reach USD 4,134.48 million in 2023, with an impressive anticipated growth to approximately USD 15,634.67 million by the end of 2033. This expansion reflects a robust compound annual growth rate (CAGR) of 14.2% from 2023 to 2033.

Autologous cell therapy manufacturing is currently at the forefront of the market, holding a significant 56.0% share in 2021. The sector’s growth is driven by advanced gene-edited cell-based products such as chimeric antigen receptor (CAR)-T cells and innovative tissue engineering solutions like Holoclar, which represent the cutting edge of modern cell therapies.

The evolution of quality standards in response to improvements in cell therapy manufacturing processes has led to enhanced product consistency, reliability, and efficacy. These advancements are vital in expanding the application and effectiveness of cell-based treatments beyond traditional methods such as blood transfusions and hematopoietic progenitor stem cell transplantation.

As the field of cell therapy continues to evolve, the market is set to experience significant growth, driven by ongoing innovations and improvements in manufacturing technologies.

Many academic centers are nowadays investing in the development of such automated devices for point-of-care manufacturing and engagement in decentralized multi-center Clinical Trials. The global cell therapy manufacturing market would thus observe a boom in the next decade. Besides, the introduction of novel therapies licensed by regulatory bodies for targeted therapeutic approaches would further propel the overall growth in the market during the projected period.

Key Takeaways from the Cell Therapy Manufacturing Market Study

  • By source, the autologous segment held a global market share of about 0% in 2021.
  • Based on indication, the cancer segment held nearly 0% in 2021 in the cell therapy manufacturing market.
  • In terms of purpose, the clinical segment accounted for around 0% of the global market share in 2021.
  • The injectable route of administration of cell therapies generated a global market share of around 0% in 2021.
  • By cell type, the hematopoietic stem cells (HSC) segment held a share of around 0% in the global cell therapy manufacturing market in 2021.
  • By end use, the hospital settings category generated a share of around 1% in 2021 in the global cell therapy manufacturing market.
  • China held a share of around 2% in 2021 in the East Asia cell therapy manufacturing market.

“Increasing number of research activities by key companies to reduce risks and get ready for a highly productive future are anticipated to drive the market. Besides, they are striving to develop innovative technologies that can assist investigators in automating their processes for gaining success in future,” says an analyst of Future Market Insights.

Competitive Landscape: Cell Therapy Manufacturing Market

Key players in the cell therapy manufacturing market are focusing on R&D activities to initiate regenerative medicine manufacturing. Moreover, they are promoting commercial manufacturing for their clients by offering novel solutions to cell therapy developers.

For instance,

  • In March 2022, Thermo Fisher Scientific presented a new large-volume electroporation system, the purpose of which is to simplify cell therapy development. The company aims to simplify the transition from clinical development to commercial manufacturing among Cell Therapy Developers.
  • Charles River Laboratories’ Memphis plant became the first CDMO in North America to manufacture commercial allogeneic cell therapies after receiving European Medicines Agency (EMA) approval in August 2022.

Get Exclusive Insights on the Cell Therapy Manufacturing Market

Future Market Insights offers a unique perspective and actionable insights on the cell therapy manufacturing market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global cell therapy manufacturing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Cell Therapy Manufacturing Market Key Players:

  1. Merck KGaA
  2. Avantor, Inc.
  3. Cell Therapies Pty Ltd
  4. Thermo Fisher Scientific
  5. Charles River Laboratories
  6. Catalent, Inc
  7. Bio-Techne
  8. Cytiva
  9. Lonza
  10. The Discovery Labs
  11. BIOCENTRIQ
  12. FUJIFILM Diosynth Biotechnologies
  13. Novartis AG
  14. Bristol-Myers Squibb Company
  15. Gilead Sciences, Inc.
  16. WuXi AppTec.
  17. OXGENE
  18. Pharmaron
  19. Aldevron
  20. FLODESIGN SONICS
  21. Exothera

A Old Full Report Analysis Click Here

Key Segments Covered in the Cell Therapy Manufacturing Market

By Source:

  • Autologous
  • Allogenic

By Indication:

  • HIV
  • Autoimmune Disorders
  • Immune Deficiencies
  • Cancer
  • Neurological Disorders

By Manufacturing Purpose:

  • Clinical
  • Commercial
  • Pre-clinical

By Route of Administration:

  • Topical
  • Injectable
  • Infusion
  • Implantable Bio-Scaffold

By Cell Type:

  • Hematopoietic (Blood-Forming) Stem Cells (HSC)
  • Skeletal Muscle Stem Cells
  • Mesenchymal Stem Cells
  • Lymphocytes
  • Dendritic Cells
  • Pancreatic Islet Cells
  • CAR-T Cells

By End User:

  • Hospital Settings
  • Intensive Outpatient Treatment Centers
  • Academic and Research Institutes
  • Specialty Clinics

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Power Device Analyzer Industry: Projected CAGR of 5.2% and Anticipated US$ 778.5 Million Market Value by 2033

The Power Device Analyzer Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the Power Device Analyzer market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for Power Device Analyzer. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The global Power Device Analyzer Market size is projected to showcase substantial growth from 2023 to 2033. According to the research report published by Future Market Insights, the global market is predicted to surpass a valuation of US$ 468.9 million in 2023. It is anticipated to hit a valuation of US$ 778.5 million by 2033. The market is estimated to showcase a modest CAGR of 5.2% from 2023 to 2033.

A high revenue stream for power device analyzers is anticipated to emerge from the consumer sector. Dynamic power device analyzers are useful for devices like fans, refrigerators, smartphones, computers, TVs, air conditioners, cutting-edge home systems, smartwatches, and other consumer electronics.

Increased demand for electronic goods and technical breakthroughs calls for intricate test and measurement solutions. The demand for high-frequency power device analyzers is projected to increase as the need for high-speed data connection grows. As many people use smartphones, tablets, laptops, and other devices, network capacity might expand, which is projected to boost market expansion. Another aspect that promotes power device analyzers’ adoption is their affordability.

Browse Full Report Here

Energy-efficient industrial electronics that can decrease waste and boost productivity are in high demand. In order to reduce dependence on fossil fuels and produce renewable energy, there is also a rising shift toward electric and hybrid automobiles.

Power device analyzers are being used frequently by the renewable energy sector. The market demand is rising as a result of governments emphasizing creating solar and wind energy projects. To reduce carbon emissions and achieve the objectives of the Paris Agreement, the future energy mix is anticipated to rely on renewable energy. As a result, several solar and wind energy projects are in the works or scheduled in a number of countries.

With investments from both the public and commercial sectors, the renewable energy industry is expanding significantly.

Key Takeaways from the Power Device Analyzer Market:

  • The global power device analyzer market expanded at a modest CAGR of 4% from 2017 to 2022.
  • In 2017, the global market size stood at US$ 369.9 million.
  • In 2022, the global market size crossed US$ 450.0 million.
  • The below 1000 A segment is likely to capture about 64% of the global power device analyzer market share in 2023.
  • The telecommunication segment is projected to capture nearly 39% of the global power device analyzer market in 2023.
  • The United States power device analyzer market is estimated to capture 23% of the global market share.
  • China is anticipated to capture 6.1% of the global market share.
  • India’s power device analyzer market is predicted to occupy 6.6% of the global market share.
  • Japan is projected to attain 6.7% of the global market share.

Recent Development Observed by FMI:

  • In May 2022, Keysight Technologies introduced their next-generation power device analyzer. Customers can evaluate entire power modules more quickly and easily with the new Double-Pulse tester (DPT).

Power Device Analyzer Market Segmentation

By Type:

  • Both AC and DC
  • AC
  • DC

By Current:

  • Below 1000 A
  • Above 1000 A

By End-user:

  • Automotive
  • Energy
  • Telecommunication
  • Consumer Electronics and Appliances
  • Medical
  • Others – Aerospace, Defense, and Government Services

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Us

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.   
Christiana Corporate,
200 Continental Drive, 
Suite 401, Newark, 
Delaware – 19713, USA   
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Disposable Endoscopes Market Set to Reach USD 6.8 Billion by 2033, Growing at 17.7% CAGR

 Disposable Endoscopes Market
Disposable Endoscopes Market

The global disposable endoscopes market is poised for remarkable growth, with a projected valuation of USD 1.3 billion by the end of 2023. The market is expected to expand significantly, achieving an estimated value of USD 6.8 billion by 2033, driven by a compound annual growth rate (CAGR) of 17.7% over the forecast period from 2023 to 2033.

Disposable endoscopes are emerging as a vital solution to the growing challenge of infections acquired during surgical procedures worldwide. Their increasing adoption is attributed to their effectiveness in minimizing cross-contamination and enhancing patient safety.

The market is also being propelled by the availability and integration of various types of disposable endoscopes, including bronchoscopes, cystoscopes, esophagoscopes, hysteroscopes, laryngoscopes, and proctoscopes. These devices offer a wide range of applications in medical diagnostics and procedures, further driving demand.

As healthcare systems continue to prioritize infection control and technological advancements, the disposable endoscopes market is set to experience substantial growth, enhancing safety and efficiency in medical procedures globally.

Growing investments in research and development activities & healthcare settings to develop novel products with an emphasis on low-cost product offerings and lesser infection exposure, are also expected to propel the disposable endoscopes market during the forecast period. Emerging startups are focusing on improving features of endoscopes to attract more customers.

The use of ultra-thin polymer fiber allows reaching anatomical sites that were formerly unreachable. Increasing preference among physicians and patients for the detection of cancer & tumors and reducing the risk of infection due to the safety and efficacy of endoscopic procedures would also favor growth in the disposable endoscopes market.

In August 2021, for instance, a customized peregrine endoscope from 3NT was launched to provide clinicians with a close-up view of the difficult-to-reach regions with sinuses to aid in the diagnosis and treatment of conditions, including polyps and cancer.

Key Takeaways: Disposable Endoscopes Market

  • Disposable bronchoscopes are the leading product type and held approximately 30.1% of the global market share in 2021.
  • By end user, hospitals are dominating the global disposable endoscopes market and are expected to exhibit a CAGR of 17.5% during the forecast period.
  • China is one of the leading manufacturers of disposable endoscopes and it held a market share of around 6.7% in 2021.
  • Germany exhibited a share of around 7.5% in the Europe disposable endoscopes market in 2021.
  • North America is considered to be the leading region and held a share of 36.8% in 2021.

“Growing emphasis on technological advancement and development of cost-effective disposable medical equipment are set to propel sales of disposable endoscopes across the globe,” says an analyst of Future Market Insights.

Competitive Landscape: Disposable Endoscopes Market

The market for disposable endoscopes is highly fragmented with the presence of several local, emerging, as well as established players. Key players are focusing on new product launches with additional features, obtaining regulatory approvals, and increasing their manufacturing capabilities to compete with their rivals.

For instance,

  • In April 2022, Ambu launched a single-use endoscope and accompanying mA scope, known as Ascope 4 Rhinolaryngo Slim and Aview 2 Advance HD monitor, which would enable fiberoptic endoscopic evaluation of swallowing.
  • In May 2021, Boston Scientific Corporation attained CE approval for its EXALT Model B. It is a single-use bronchoscope, a device made for bedside operations in the ICU and operating room.

Key Players:

  • Ambu A/S
  • Olympus America
  • Boston Scientific Corporation
  • Fujifilm Holdings Corporation
  • NeoScope Inc.
  • Coloplast Corp
  • Endotherapeutics Pty Ltd
  • Laborie
  • Shenzhen Tianlang Medical
  • Intersurgical
  • Teleflex Incorporated.
  • Bell Medical Inc.
  • PENTAX Medical
  • CooperSurgical Inc.
  • Meditrina, Inc.
  • UroViu Corporation
  • Adler MicroMed, Inc.
  • Advin Health Care
  • KARL STORZ SEACON

A Old Full Report Analysis Click Here

Disposable Endoscopes Market Segmentation

By Product:

  • Bronchoscopes
  • Cystoscopes
  • Duodenoscopes
  • Esophagoscopes
  • Hysteroscopes
  • Laryngoscopes
  • Proctoscopes
  • Ureteroscopes

By End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Diagnostic Center

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

North America Electrical Testing Services Market Projected to Grow at 6% CAGR and Reach US$ 4.5 Billion by 2033

The North America Electrical Testing Services Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the North America Electrical Testing Services market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for North America Electrical Testing Services. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The North America Electrical Testing Services Market is currently witnessing a substantial upswing in demand, predominantly propelled by a heightened emphasis on regulatory compliance and safety protocols within industrial plants and manufacturing facilities. This increased focus is a direct response to the implementation of stringent regulations aimed at averting penalties associated with negligence and non-compliance. Consequently, businesses are increasingly embracing electrical testing services to guarantee that their work environments adhere to industry standards and are free from potential hazards.

Furthermore, the imperative to minimize downtime and uphold uninterrupted operations is escalating, further amplifying the necessity for these indispensable services. Projections indicate that the North America electrical testing services market is on track to achieve a valuation of US$ 2.5 billion in 2023, with expectations of reaching US$ 4.5 billion by 2033. This trajectory underscores a noteworthy compound annual growth rate (CAGR) of 6% from 2023 to 2033. As industry participants acknowledge the pivotal role of electrical testing services in ensuring compliance and operational continuity, the market is strategically positioned for sustained growth over the ensuing decade.

Browse Full Report Here

Electrical testing services have become essential components in ensuring regulatory compliance, thereby mitigating the risk of penalties associated with negligence, non-compliance, and the creation of hazardous work environments. This has resulted in a significant rise in the global demand for these services, driven by an increasing emphasis on safety within industrial plants and manufacturing units, coupled with a concerted effort to minimize operational downtime.

Projections indicate that the electrical testing services market is poised for substantial growth in the foreseeable future, with several key factors propelling this expansion. These factors include the accelerating pace of railway electrification, advancements in steel production, and a growing focus on systematic equipment testing to proactively address potential breakdowns.

The crucial role played by these services in preventing issues such as short circuits, lubricant leakage, corrosion, and wiring faults has been a driving force behind the expansion of the global electrical testing services market. Manufacturing industries and power generation plants, in particular, are increasingly relying on comprehensive electrical equipment testing, contributing to the market’s upward trajectory.

Furthermore, the increasing investment in the development of electrical infrastructure to ensure accessible and uninterrupted electricity in key regions, including Mexico, the United States, and Canada, is expected to further bolster the demand for electrical testing services. Notably, North America is anticipated to witness a surge in the sales of electrical testing services, driven primarily by the implementation of stringent regulatory frameworks mandating regular inspections of electrical equipment and power distribution lines to prevent potential hazards.Top of Form

Key Takeaways

  • Canada’s electrical testing services industry is projected to grow with a CAGR of 6.2% during the forecast period.
  • The demand for electrical testing services in Mexico is expected to grow with a significant CAGR of 6.5% during the forecast period.
  • By service type, the transformer testing segment is projected to grow with a CAGR of 6.8% during the forecast period.
  • By end-user, the power generation station segment is projected to grow with a CAGR of 7.1% during the forecast period.

“Increasing investments to develop electrical infrastructure is expected to drive market growth during the forecast period,” comments an FMI analyst.

Competitive Landscape

The North American electrical testing services market is highly competitive, with numerous prominent industry players making substantial investments in increasing their manufacturing capabilities.

The key industry players are Schneider Electric, Siemens AG, Eaton Corporation plc, General Electric Company, ABB Inc., Power Products & Solutions, American Electrical Testing, Haugland Group LLC, Dekra, TCS Electrical Co., Phase One Electric, Intran, GEM Electrical Services, Electric Power Systems.

Some recent developments in the North American electrical testing services market are:

  • In June 2023, ABB Inc. declared the acquisition of Munich-based smart home products leader, Eve Systems GmbH, with operations in Europe and the United States.
  • In June 2023, Siemens Digital Industries Software integrated Supplyframe™ Design-to-Source Intelligence platform with Siemens Xcelerator portfolio enhancing real-time supply chain intelligence for comprehensive digital twin technology.
  • In August 2021, RESA Power, a U.S.-based electrical solutions provider, announced the acquisition of EPIC Energy Solutions, LLC, an electrical testing company. This acquisition enables RESA Power to enhance its testing capabilities in the Midwest region.
  • Siemens Mobility acquired Optrail in June 2023 to broaden its Train Planning System capabilities.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global North America electrical testing services market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the North American electrical testing services market, the report is segmented on the basis of end-use (power generation stations, transmission and distribution stations, steel plants, major refineries, railways, other industrial (laboratory, etc.), data centers, healthcare and hospitality, and commercial establishments) and service type (transformer testing, circuit breaker testing, protection testing, battery testing, rotating equipment vibration testing, motors/generator testing, and thermographic testing) across two major countries (United States and Canada).

For Expert Guidance in Purchasing this Report, Contact our Sales Representatives

Key Segments Profiled in the North America Electrical Testing Services Industry Survey

By End Use:

  • Power Generation Stations
  • Transmission and Distribution Stations
  • Steel Plants
  • Major Refineries
  • Railways
  • Other Industrial (Laboratory, etc)
  • Data Centers
  • Healthcare and Hospitality
  • Commercial Establishments

By Service Type:

  • Transformer Testing
  • Circuit Breaker Testing
  • Protection Testing
  • Battery Testing
  • Rotating Equipment Vibration Testing
  • Motors/Generator Testing
  • Thermographic Testing

By Country:

  • United States
  • Canada

Author By:

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

About Us

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Magnetic Drive Pump Market Poised for Steady Growth with a 6.4% CAGR, Projected to Reach US$ 1,251 Million by 2033

The magnetic drive pump market is expected to be worth US$ 660.2 million in 2022 and US$ 672.5 million in 2023. According to Future Market Insights, the magnetic drive pump market would grow at a CAGR of 6.4% between 2023 and 2033, totaling roughly US$ 1,251 million by 2033.

Demand for global magnetic drive pumps waned in 2020 due to the outbreak of COVID-19. With the construction industry in recovery mode, the long-term outlook of the market is expected to remain positive.
Expansion of the construction and mining industries is expected to increase the demand for heavy machinery and equipment, increasing sales in the magnetic drive pump market. As per FMI, increasing application in construction and mining industries is projected to register steady growth across China, India, and Indonesia.

Browse Full Report Here

As per FMI’s analysis, the rapid adoption of technologically advanced equipment and machinery, coupled with increasing application for water treatment activities will spur sales. Backed by these aforementioned factors, the market is expected to surpass US$ 1.35 Billion by 2031.

Key Takeaways From the Market Report:

  • In terms of pump type, the centrifugal pumps segment is projected to hold 52.6% of the total magnetic drive pump market share.
  • Applications of magnetic drive pumps are anticipated to continue rising in the water treatment and mining sector, accounting for 15.6% and 13.3%, respectively.
  • Stainless steel is expected to remain the most preferred casing material for magnetic drive pump services
  • China is anticipated to emerge as an attractive market, capturing 40.2% of the East Asia magnetic drive pump market share.
  • Germany is projected to lead Europe’s magnetic drive pump market, growing at a 5.1% CAGR.
  • India will continue experiencing high demand for magnetic drive pumps, capturing 31.8% of the South Asia Pacific market share.
  • Japan and South Korea will collectively account for 8% of the global market share.

“Integration of advanced technology due to focus on automation in construction and mining industries is pushing the sales of advanced magnetic drive pumps. CAPEX investments and increase in water treatment projects also are expected to provide lucrative opportunities for the magnetic drive pump market. Steered by this, some of the leading OEMs are investing in strategic alliances, partnerships and product innovations to gain competitive advantage in the global market. These partnerships will allow companies to improve their production capacity and strengthen their technical expertise,” says an FMI analyst.

Competitive Landscape

The market is expected to be primarily consolidated, with key players accounting for more than half of the market share. These players are likely to invest in new technology developments and expansion of their networks in order to maintain their market shares.

Global Magnetic Drive Pump Market by Category

By Pump Type:

  • Centrifugal Pumps
  • Positive Displacement Pumps

By Flow Rate:

  • Up to 80 m3/hr
  • 81 – 200 m3/hr
  • 201 – 500 m3/hr
  • Above 501 m3/hr

By Casting Material:

  • Stainless Steel
  • Alloy
  • Engineering Plastic
    • PP
    • ETFE
    • PFA
    • CRETFE

By Application:

  • Mining
  • Chemical Manufacturing and Processing
  • Bio-Fuels and Refineries
  • Metal Plating and Finishing
  • Fume Scrubbing
  • Food Processing
  • Water Treatment
  • Surface Treatment
  • Desalination
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Infant Incubators Market Projected to Reach USD 538 Million by 2033, Growing at 4.5% CAGR

Global Infant Incubators Industry
Global Infant Incubators Market

The global infant incubators market is set to achieve a valuation of USD 345.3 million in 2023, with expectations to grow at a compound annual growth rate (CAGR) of 4.5% over the next decade. By 2033, the market is projected to reach approximately USD 538 million.

Intensive care incubators have emerged as the leading product segment, capturing about 71.6% of the market share in 2022. This significant share highlights their critical role in providing essential care for premature and critically ill infants.

The growth of the infant incubators market is driven by advancements in neonatal care technology and increasing awareness of the importance of specialized care for newborns. As the healthcare sector continues to focus on improving neonatal outcomes, the demand for advanced incubators is expected to rise, further propelling market expansion.

The surge in the Global Infant incubator industry is driven by a heightened awareness regarding newborn health, an increase in the prevalence of chronic infections, and a rise in cases of sudden unexpected deaths among infants in healthcare facilities. Moreover, the ongoing emergence of various epidemics and the associated health risks have further amplified the demand for intensive care incubators across healthcare facilities worldwide, facilitating market expansion.

Besides, the growing acceptance of infant incubators by various end users, including hospitals, as well as pediatric & neonatal intensive care units, would give the market a boost in the approaching years. The U.S. healthcare sector has been focusing on the importance of collaborative strategies by government bodies, which would boost the advancement of healthcare facilities. The CDC and the March of Dimes to assist state-based PQCs in improving maternal and infant health outcomes statewide in a measurable manner, for instance, established the National Network of Perinatal Quality Collaboratives (NNPQC).

These aforementioned factors will boost the market shortly, as key companies are also concentrating on acquisitions and the development of novel products with improved efficacy in terms of environmental stability, infection protection, and durability.

Key Takeaways from the Infant Incubators Market Study

  • By product, the intensive care incubators segment held approximately 3% of the global market share in 2021.
  • Based on end users, the hospital segment generated a market share of around 7% in 2021.
  • East Asia is considered to be the leading region in the market and it held a share of 3% in 2021.
  • Europe accounted for a value share of 7% in 2021 owing to the increasing number of preterm births in the region.
  • China is projected to exhibit growth at a lucrative CAGR of 8 during the forecast period.

“Increased initiatives by government bodies to promote health safety solutions and growing prevalence of chronic illnesses among infants in healthcare facilities are estimated to propel the market,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Infant Incubators Market Competitive Landscape

Although infant incubator producers are functioning at full capacity, demand has surpassed supply in recent years with the rising prevalence of chronic illnesses. The gap has had an impact on a wide range of end users, including healthcare practitioners and other industrial users.

The global infant incubators market is fragmented, and there is a wide range of regional, up-and-coming, as well as established businesses operating within it. Key stakeholders have started conducting promotional activities to introduce unique infant incubators with improved efficacy.

For instance,

  • In April 2022, nearly two hundred portable incubators that were developed by utilizing technology co-invented by a Stanford MBA more than 10 years ago, were sent to Ukraine to offer life-saving warmth to babies born prematurely in hospitals and bomb shelters.
  • Dräger’s new Ponta and Ambia ceiling supply systems, which went into effect on September 30, 2021, give hospitals a great deal of flexibility when designing workstations that support particular clinical requirements in the operating room, ICU, and NICU.

Key Segments:

By Product:

  • Intensive Care
  • Transport

By End User:

  • Hospitals
  • Pediatric and Neonatal Intensive Care Units
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube